Follow-The-Filings

Security

Annovis Bio Inc. · COM

Equity holders as of 2025 Q4 (each manager’s latest book)

4 owners 1 new max 0.0% (Vanguard Group Inc.)

owners 4
max % 0.0%
tracked value $9M
qoq N 1 A 2

holders

sorted by % of portfolio · long equity only

manager % port activity shares value history
Vanguard Group Inc. 2025 Q4 0.0% Add 0.00 pp 923,201 $3M hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 stale 0.0% Add 0.00 pp 1,187,499 $3M hist
Two Sigma Investments, LP 2025 Q4 0.0% Exit 0.00 pp 551,837 $2M hist
Renaissance Technologies LLC 2026 Q1 stale 0.0% New 0.0% 347,600 $775 hist

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $0.00 $0.00 $0.00
Gross profit
Gross margin
Net income -$56.2M -$24.59M -$28.85M
Net margin

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $10.21M
Total non-current assets * $0.00
Total assets $10.21M $13.93M $21.08M
Total current liabilities $4.28M $3.88M $3.64M
Total non-current liabilities * $13.68M $737,000 $595,000
Total equity -$7.75M $9.31M $16.85M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$39.97M -$21.89M -$25.62M
Cash from investing
Cash from financing $17.34M $26.69M $34.6M
Net change in cash -$22.62M $4.8M $8.98M

ownership over time

filing count by report period · click a bar for that quarter’s holders